iRhythm Holdings, Inc.

IRTC ·Healthcare, Medical Devices, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Revenue $224.2M $199.4M $208.9M $192.9M $186.7M $158.7M $164.3M $147.5M
Cost of Revenue $61.0M $58.0M $60.8M $55.8M $53.8M $49.5M $49.3M $46.1M
Gross Profit $163.2M $141.4M $148.1M $137.1M $132.9M $109.2M $115.1M $101.5M
Gross Margin 72.8% 70.9% 70.9% 71.1% 71.2% 68.8% 70.0% 68.8%
Operating Expenses
Research & Development — — — — — — — —
SG&A Expense $131.7M $135.9M $122.0M $124.2M $126.4M $120.0M $99.8M $103.4M
Operating Income $-2.5M $-16.2M $2.3M $-8.4M $-18.7M $-32.6M $-4.1M $-50.3M
Operating Margin -1.1% -8.1% 1.1% -4.4% -10.0% -20.5% -2.5% -34.1%
Interest Expense $3.3M $3.3M — $3.3M $3.3M $3.3M — $3.3M
Pretax Income $-381.0K $-13.4M $6.0M $-5.2M $-14.4M $-30.0M $-1.2M $-46.0M
Income Tax Expense $0 $500.0K $447.0K $24.0K $-183.0K $665.0K $151.0K $188.0K
Net Income $-381.0K $-13.9M $5.6M $-5.2M $-14.2M $-30.7M $-1.3M $-46.2M
Net Margin -0.2% -7.0% 2.7% -2.7% -7.6% -19.3% -0.8% -31.3%
EPS (Basic) $-0.01 $-0.43 $0.18 $-0.16 $-0.44 $-0.97 $-0.03 $-1.48
EPS (Diluted) $-0.01 $-0.43 $0.18 $-0.16 $-0.44 $-0.97 $-0.03 $-1.48
Shares Outstanding (Basic) 32.9M 32.5M 32.0M 32.2M 32.0M 31.6M 31.2M 31.3M
Shares Outstanding (Diluted) 32.9M 32.5M 32.0M 32.2M 32.0M 31.6M 31.2M 31.3M
Dividends Per Share — — — — — — — —
← Newer Page 1 of 6 Older →